Increase in CD14+HLA-DR−/low Myeloid-Derived Suppressor Cells in Hepatocellular Carcinoma Patients and Its Impact on Prognosis

Cancer Immunology, Immunotherapy - Germany
doi 10.1007/s00262-013-1447-1